Macquarie Group
GMAB icon

Macquarie Group’s Genmab GMAB Stock Holding History

Macquarie Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-323
Closed -$6K – 1688
2025
Q1 		$6K Buy
323
+9
+3% +$189 ﹤0.01% 1673
2024
Q4 		$7K Buy
314
+84
+37% +$1.85K ﹤0.01% 1588
2024
Q3 		$6K Buy
230
+13
+6% +$348 ﹤0.01% 1634
2024
Q2 		$5K Sell
217
-108
-33% -$3.06K ﹤0.01% 1711
2024
Q1 		$10K Sell
325
-22
-6% -$646 ﹤0.01% 1589
2023
Q4 		$11K Sell
347
-3,249,389
-100% -$102M ﹤0.01% 1619
2023
Q3 		$115M Sell
3,249,736
-347,523
-10% -$13.2M 0.14% 191
2023
Q2 		$137M Buy
3,597,259
+112,627
+3% +$4.49M 0.16% 181
2023
Q1 		$132M Buy
3,484,632
+347,437
+11% +$13.4M 0.16% 175
2022
Q4 		$133M Sell
3,137,195
-121,121
-4% -$4.99M 0.16% 164
2022
Q3 		$105M Sell
3,258,316
-280,994
-8% -$9.87M 0.13% 214
2022
Q2 		$115M Sell
3,539,310
-44,347
-1% -$1.44M 0.13% 204
2022
Q1 		$130M Sell
3,583,657
-26,209
-0.7% -$899K 0.1% 239
2021
Q4 		$143M Sell
3,609,866
-526,081
-13% -$21.9M 0.12% 222
2021
Q3 		$181M Sell
4,135,947
-21,649
-0.5% -$972K 0.15% 158
2021
Q2 		$170M Buy
+4,157,596
New +$160M 0.14% 173

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Macquarie Group's GMAB Position: Q2 2025 in Review

Macquarie Group sold out of Genmab (GMAB) in Q2 2025, closing a stake of 323 shares — an estimated $6K sold.

Macquarie Group first reported a position in GMAB in Q2 2021 and held it in 16 quarters. The position peaked at $181M in Q3 2021. 218 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Macquarie Group reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Macquarie Group sold 323 Genmab shares in Q2 2025, an estimated $6K.
  • Macquarie Group first reported a position in Genmab in Q2 2021 and held it in 16 quarters.
  • Macquarie Group's Genmab position peaked at $181M in Q3 2021.
  • 218 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.